The Hippo pathway in clear cell renal cell carcinoma (ccRCC): a nexus with the VHL disruption?
Background: Clear cell renal cell carcinoma (ccRCC) represents 70% of kidney cancers, with 20–50% recurrence risk after surgery. Despite therapeutic advances, no reliable biomarkers have been identified for patient stratification or treatment response prediction. While VHL gene alterations are well-...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2026-04-01
|
| Серии: | Translational Oncology |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S1936523326000586 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|